Clinical Trial Update: Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for VB4-845 Injection in non-muscle invasive bladder cancer is ongoing, with status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• VB4-845 Injection (VB4-845)

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Non-Muscle Invasive Bladder Cancer | Phase 3 | Status: UNKNOWN